Investor Relations & Capital Introduction in Laval

Laval is a large city on Île Jésus, just north of Montreal, and the third-largest city in Quebec. For founders, it offers a strong biotechnology and pharmaceutical cluster and access to Montreal's investors.

Why Laval Matters for Capital Raising

Laval was created in 1965 by merging the municipalities of Île Jésus into a single city.

The Cité de la Biotech in Laval hosts pharmaceutical companies, research centres and biotech startups, including the Armand-Frappier institute of INRS.

Laval benefits from Quebec's research tax credits and close links to Montreal's universities and venture funds.

What Laval Investors Examine

For biotech and pharmaceutical companies, scientific data and regulatory pathways are examined closely.

Investors value experienced management and strong partnerships.

Engagement and Access

GCN connects founders with Laval investors, life sciences partners and the wider Montreal investor community through conference programming and private sessions.

Sectors where we see consistent Laval interest include biotechnology and pharmaceuticals, advanced manufacturing, logistics, real estate and consumer brands.

Partner with Global Capital Network

Whether you are raising into Laval or allocating from it, our team can discuss how our investor relations infrastructure applies to your objectives.